PROTOCOL FOR HUMAN EXPOSURE TO OPIOIDS AND CONCENTRATED MEDETOMIDINE USED IN FIELD APPLICATIONS.
Journal
Journal of zoo and wildlife medicine : official publication of the American Association of Zoo Veterinarians
ISSN: 1042-7260
Titre abrégé: J Zoo Wildl Med
Pays: United States
ID NLM: 8915208
Informations de publication
Date de publication:
Jan 2024
Jan 2024
Historique:
accepted:
20
09
2023
medline:
22
1
2024
pubmed:
22
1
2024
entrez:
22
1
2024
Statut:
ppublish
Résumé
Wildlife professionals routinely use potent sedatives and anesthetics when chemically immobilizing wildlife and zoo species in remote environments. Accidental exposure to these prescription veterinary drugs is rare but could be rapidly fatal. Commonly used agents include opioids and α
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
873-878Références
Al-Azzawi M, Alshami A, Douedi S, Al-Taei M, Alsaoudi G, Costanzo E. Naloxone-induced acute pulmonary edema is dose-dependent: a case series. Am J Case Rep. 2021. doi:10.12659/AJCR.929412
Burnside WM, Flecknell PA, Cameron AI, Thomas AA. A comparison of medetomidine and its active enantiomer dexmedetomidine when administered with ketamine in mice. BMC Vet Res. 2013. doi:10.1186/1746-6148-9-48
Elkattawy S, Alyacoub R, Ejikeme C, Noori MAM, Remolina C. Naloxone induced pulmonary edema. J Community Hosp Intern Med Perspect. 2021; 11(1):139–142.
Farkas A, Lynch MJ, Westover R, Giles J, Siripong N, Nalatwad A, Pizon AF, Martin-Gill C. Pulmonary complications of opioid overdose treated with naloxone. Ann Emerg Med. 2020;75(1):39–48.
Greenberg M, Rama A, Zuba JR. A protocol for the emergency treatment of alpha-2 agonist overdose using atipamezole, a selective alpha-2 antagonist. Internet J Toxicol. 2017. doi:10.5580/IJTO.52514
Greenberg M, Rama A, Zuba JR. Atipamezole as an emergency treatment for overdose from highly concentrated alpha-2 agonists used in zoo and wildlife anesthesia. Am J Emerg Med. 2018;36(1):136–138.
Haymerle A, Fahlman A, Walzer C. Human exposures to immobilizing agents: results of an online survey. Vet Rec. 2010;167(9):327–332.
Karhuvaara S, Kallio A, Salonen M, Tuominen J, Scheinin M. Rapid reversal of α2-adrenoreceptor agonist effects by atipamezole in human volunteers. Br J Clin Pharmacol. 1991;31(2):160–165.
Karhuvaara S, Kallio A, Scheinin M, Anttila M, Salonen JS, Scheinin H. Pharmacological effects and pharmacokinetics of atipamezole, a novel α2-adrenoceptor antagonist—a randomized, double-blind cross-over study in healthy male volunteers. Br J Clin Pharmacol. 1990;30(1):97–106.
Karhuvaara S, Kallio A, Scheinin M, Koulu M, Scheinin H, Viikari J. Tolerability and effects of atipamezole, a novel alpha
Kock M, Burrows R (eds.). Chemical and physical restraint of African wild animals. 3rd ed. Michael D Kock, International Wildlife Veterinary Services (Africa); 2021.
Kreeger TJ, Arnemo JM. Handbook of wildlife chemical immobilization. 5th ed.; Published by authors; 2018.
O'Dell JH, Kock MD, Thompson PN, Meyer LCR. Minimum effective naltrexone dose to antagonize etorphine immobilization and prevent the complications of renarcotisation in domestic goats. Vet Rec. 2017. doi:10.1136/vr.104435
Reid JL. Alpha-adrenergic receptors and blood pressure control. Am J Cardiol. 1986;57(9):6E–12E.
Scheinin H, Aantaa R, Anttila M, Hakola P, Helminen A, Karhuvaara S. Reversal of the sedative and sympatholytic effects of dexmedetomidine with a specific α-adrenoceptor antagonist atipamezole. Anesthesiology. 1989;89(3):574–584.
Szabo Z, Venter DJ, Luyt EDC, Raath C. The use of thiafentanil oxalate and azaperone for reversible immobilization of African buffalo (
Wolfe LL, Lance WR, Miller MW. Immobilization of mule deer with thiafentanil (A-3080) or thiafentanil plus xylazine. J Wildl Dis. 2004;40(2): 282–287.
Zuba, JR., Greenberg, M. Use of naltrexone and atipamezole in emergency response to human exposure to ultra-potent opioids and alpha-2 agonists in zoo and wildlife medicine. In: Miller ER, Lamberski N, Calle PP (eds.). Miller-Fowler's zoo and wild animal medicine, Volume 9, Current therapy. St. Louis (MO): Elsevier; 2019. p. 164–176.